Get the Stockscreener App
197.37
0.32%
-1.29
Davita Inc stock is traded at $197.37, with a volume of 232.08K.
It is down -0.32% in the last 24 hours and up +29.93% over the past month.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
See More
Previous Close:
$198.66
Open:
$199.93
24h Volume:
232.08K
Relative Volume:
0.27
Market Cap:
$12.69B
Revenue:
$13.84B
Net Income/Loss:
$1.10B
P/E Ratio:
18.94
EPS:
10.4185
Net Cash Flow:
$1.49B
1W Performance:
-0.85%
1M Performance:
+29.93%
6M Performance:
+64.68%
1Y Performance:
+42.96%
1-Day Range:
$197.66
$202.56
1-Week Range:
$194.10
$202.56
52-Week Range:
$101.00
$202.69
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
197.69 | 12.75B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
394.43 | 87.09B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
174.45 | 15.33B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
21.70 | 12.09B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
105.22 | 10.36B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
DaVita stock (US23918K1088): Q4 2025 revenue beat and debt load stay in focus - AD HOC NEWS
DaVita Honors Extraordinary Nurses With the 2026 DAISY Awards - ACCESS Newswire
DaVita stock (US23918K1088): solid Q1 2025 earnings keep dialysis specialist in focus - AD HOC NEWS
DaVita Inc stock (US23804L1035): earnings, buyback and outlook after strong first quarter - AD HOC NEWS
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
AI shows promise as health systems invest in chronic disease tech - Modern Healthcare
DaVita ESG Roadmap Links 2030 Care Goals To Core Operations - Yahoo Finance
DaVita Inc. Lifts Outlook After Q1 Earnings Beat - TipRanks
DaVita stock (US23918K1088): Insider sale follows strong Q1 2026 earnings - AD HOC NEWS
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Best Value Stocks to Buy for May 19th - Yahoo Finance Australia
DaVita stock (US23918K1088): solid Q1 2026, buyback boost and kidney care focus - AD HOC NEWS
Davita chief compliance officer James Hearty sells $2.9m in stock - Investing.com India
DaVita Inc (DVA) Stock Price, Trades & News - GuruFocus
DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals - PR Newswire
Zacks.com featured highlights include DaVita, Antero Resources, PBF Energy and Popular - Yahoo Finance Singapore
DaVita stock (US23918K1088): dialysis provider in focus after strong share price run - AD HOC NEWS
DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill
How Investors Are Reacting To DaVita (DVA) Q1 Earnings Beat And Aggressive Share Buybacks - simplywall.st
DaVita Inc (DVA) Stock Up 3.7% but GF Value Says Overvalued -- GF Score: 89/100 - GuruFocus
DaVita stock (US23918K1088): shares stay near 2026 highs after latest pullback - AD HOC NEWS
DaVita Inc. stock (US23918K1088): strong year-to-date rally despite latest pullback in healthcare se - AD HOC NEWS
DaVita Inc (DVA) Stock Up 3.7% but GF Value Says Overvalued -- G - GuruFocus
The 5 Most Interesting Analyst Questions From DaVita’s Q1 Earnings Call - Yahoo Finance
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Does DaVita Insider Equity Move Signal Governance in Russell 1000? - Kalkine Media
DaVita CFO & Treasurer Joel Ackerman Sells 34% Of Holding - simplywall.st
DaVita stock (US23918K1088): TD Cowen raises price target after Q1 earnings - AD HOC NEWS
Insider Sell Alert: David Maughan Sells 20,529 Shares of DaVita Inc (DVA) - GuruFocus
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita COO David Maughan sells $4.09 million in company stock By Investing.com - Investing.com South Africa
DaVita(DVA.US) Officer Sells US$4.09 Million in Common Stock - Moomoo
What Does DaVita Inc.'s (NYSE:DVA) Share Price Indicate? - 富途牛牛
DaVita stock (US23918K1088): Q1 EPS beat and raised full-year guidance - AD HOC NEWS
What Are Wall Street Analysts' Target Price for DaVita Stock? - Yahoo Finance
DaVita Stock On Fire: Up 32% With 7-Day Winning Streak - Trefis
DaVita Stock Rockets 32% With 7-Day Winning Streak - Trefis
Here's Why DaVita HealthCare (DVA) is a Strong Momentum Stock - Yahoo Finance
DaVita stock (US23918K1088): TD Cowen raises price target to $201 - AD HOC NEWS
DaVita Stock 6-Day Winning Spree: Stock Climbs 31% - Trefis
Insider Sell: Joel Ackerman Sells 51,471 Shares of DaVita Inc (D - GuruFocus
DaVita (DVA) Leads Goldman Sachs' Buyback Aristocrats Index with Aggressive Share Repurchases - GuruFocus
DaVita HealthCare (DVA) Is Up 30.99% in One Week: What You Should Know - Yahoo Finance
DaVita stock (US23918K1088): Q1 beat and raised guidance lift shares - AD HOC NEWS
DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amidst a Robust Market Position - DirectorsTalk Interviews
DaVita Inc. stock (US23918K1088): Q1 2026 beat lifts shares after guidance hike - AD HOC NEWS
DaVita Inc. stock (US23918K1088): Q1 2026 earnings and share buybacks lift sentiment - AD HOC NEWS
Evaluating DaVita (DVA) After A Strong Share Price Rally And Mixed Valuation Signals - Yahoo Finance
DaVita Stock 5-Day Winning Spree: Stock Climbs 31% - Trefis
Insider Sell: James Hearty Sells Shares of DaVita Inc (DVA) - GuruFocus
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.25%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):